Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya
March 2015
Click for full info +Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya
 | March 2015 |
In this Journal Article:
Health Risk(s):HIV STI / STD Unintended Pregnancy
Product Type(s):Hormonal Contraceptives
Topic(s):Drug Interactions
Full Info:
Resource Type:
Citation:
Todd, C.S., Deese, J., Wang, M., Hubacher, D., Steiner, M.J., et al. (2015). Contraception, 91(3), 248-252.
Authors:
Todd, C.S., Deese, J., Wang, M., Hubacher, D., Steiner, M.J., et al.
Health Risks(s):
- HIV
- STI / STD
- Unintended Pregnancy
Product type(s):
- Hormonal
Topic(s):
- DrugInteractions
URL of resource:
http://www.contraceptionjournal.org/article/S0010-7824%2814%2900732-X/abstract